Phase I trial of intravesical Bacillus Calmette-Guerin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-Guerin treatment Article (Web of Science) Early Access (Web of Science)

cited authors

  • Alanee, Shaheen; Sana, Sherjeel; El-Zawahry, Ahmed; Peabody, James; Pearce, Tiffany; Adams, Nicole; Deebajah, Mustafa; Crabtree, Jane; Delfino, Kristin; McVary, Kevin; Robinson, Kathy; Rao, Krishna

publication date

  • May 8, 2021


published in



  • Bacillus Calmette–
  • Bladder cancer
  • Cystectomy
  • Gué
  • Non-muscle invasive
  • Pembrolizumab
  • rin